Effect of combining angiotensin receptor blockers and ACE inhibitors on cardiovascular disease

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 2, Issue SUPPL. 1, 2001, Pages

  Morgan, Trefor ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

ACE Inhibitors; Angiotensin II; AT1 receptor antagonists; Cardiac hypertrophy; Hypertension

Indexed keywords

EID: 0013243224     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/14703203010020013901     Document Type: Review

References (31)

1. Griffin SA, Brown WC, MacPherson F et al. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991; 17:626-35.
2. Morgan TO, Aubert J-F, Wang Q. Sodium, angiotensin II, blood pressure and cardiac hypertrophy. Kidney Int 1998; 54(Suppl 67):S213-S215.
3. Yuan BX, Leenen FH. Dietary sodium intake and left ventricular hypertrophy in normotensive rats. Am J Physiol 1991; 261:H1397-H1401.
4. Young M, Head G, Funder JW. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol 1995; 269:E657-E662.
5. Liu YH, Yang XP, Sharov VG et al. Effects of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin type 2 receptors. J Clin Invest 1997; 99:1926-35.
6. Unger T, Chung O, Scikos T et al. Angiotensin receptors. J Hypertens 1996; 14 (Suppl. 5):S95-S103.
7. van Kats JP, Danser AH, van Meegen JR, Sassen LM, Verdouw PD, Schalekamp MA. Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation 1998; 98:73-81.
8. Moldenhauer GK, Smith MD, Di Nicolantonio R, Doyle AE, Morgan TO. Angiotensins II and III prevent captopril-induced renin release in the rat. Clin Exp Pharmacol Physiol 1988; 15:113-21.
9. Mooser V, Nussberger J, Juillerat L et al. Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition. J Cardiovasc Pharmacol 1990; 15:276-82.
10. Duncan AM, Burrell LM, Kladis A, Campbell DJ. Effects of angiotensin converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction. J Cardiovasc Pharmacol 1996; 28:746-54.
11. Esther CR Jr, Marino EM, Howard TE et al. The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest 1997; 99:2375-85.
12. Kobori H, Harrison-Bernard LM, Navar G. Renal expression of angiotensinogen protein in angiotensin II-infused hypertensive rats maintained on high salt diet [abstract]. Hypertension 2000; 36:695.
13. Richer C, Bruneval P, Menard J, Giudicelli JF. Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats. Hypertension 1998; 31:692-8.
14. Webb RL, Navarrete AE, Davis S, De Gasparo M. Synergistic effects of combined converting enzyme inhibition and angiotensin II antagonism on blood pressure in conscious telemetered spontaneously hypertensive rats. J Hypertens 1998; 16:843-52.
15. Morgan TO, Griffith C, Delbridge L. 2000. (Unpublished data).
16. Yamazaki T, Komuro I, Kudoh S et al. Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy. Circ Res 1995; 77:258-65.
17. Kim S, Zhan Y, Izumi Y, Iwao H. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats. Hypertension 2000; 35:769-74.
18. Ménard J, Campbell DJ, Azizi M, Gonzales MF. Synergistic effects of ACE inhibition andAng II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats. Circulation 1997; 96:3072-8.
19. Morgan T, Griffiths C, Delbridge L. Complete blockade of angiotensin II causes cardiac involution in normotensive rats [abstract]. J Hypertens 2000; 18(Suppl 4):S29.
20. Ots M, Mackenzie HS, Troy JL, Rennke HG, Brenner BM. Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation. J Am Soc Nephrol 1998; 9:224-30.
21. Gradman AH, Arcuri KE, Goldberg AI et al. A randomised, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension. Hypertension 1992; 5:247S-51S.
22. Smith DHG, Neutel JM, Morgenstern P. Once-daily telmisartan compared with enalapril in the treatment of hypertension. Adv Therapy 1998; 15(4):229-40.
23. 1) receptor blockade in hypertensive women: Benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide. Am J Hypertens 2000; 13:504-11.
24. Fogafi R, Zoppi A, Corradi L et al. Adding losartan to lisinopril therapy in patients with hypertension: Assessment by 24-hour ambulatory blood pressure monitoring. Curr Ther Res Clin Exp 1999; 60:326-34.
25. Sever P. Intra-individual responses to blockade of the renin-angiotensin system by an ACE-I (lisinopril) and an angiotensin receptor antagonist (candesartan). JRAAS 45 2000; 1:104.
26. Tonkon M, Awan N, Niazi I et al. A study of the efficacy and safety of irbesartan in combination with conventional therapy, including ACE inhibitors, in heart failure. Int J Clin Pract 2000; 54:11-8.
27. McKelvie RS, Yusuf S, Pericak D et al. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators [see comments]. Circulation 1999; 100:1032-4.
28. Mogensen CE, Cooper ME, on behalf of the CALM Study Group. Reduction of blood pressure and albuminuria in hypertensive diabetic patients using candesartan, lisinopril and their combination (dual blockade) [abstract]. J Hypertens 2000; 18 (Suppl. 2):S83.
29. Ruilope LM, Aldigier JC, Ponticelli C, Oddou-Stock P, Botteri F. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. J Hypertens 2000; 18:89-95.
30. Russo D, Pisani A, Balletta MM, De Nicola L, Savino FA, Andreucci M, Minutolo R. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am J Kidney Dis 1999; 33:851-6.
31. Kincaid-Smith PS, Fairley KF, Packham D. Randomised controlled crossover study of the effect on proteinuria of adding an angiotensin II-receptor antagonist (ARA) to an angiotensin converting enzyme inhibitor (ACEI). JASN 2000; 11:349A.